Enveric Biosciences, Inc.
ENVB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000890821
No open-market purchases or sales by Enveric Biosciences, Inc. insiders were filed in the last 90 days; 24 institutions reported holding it in 13F filings for Q2 2026, worth $736.8K in total; no superinvestor holds it.
Holders of 5% or more of ENVB
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Enveric Biosciences, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Armistice Capital, LLC | 13G | 9.99%405.1K shares | – | Feb 14, 20243 filings | Aug 14, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
37 Schedule 13D and 13G filings on Enveric Biosciences, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 20264:08 PM ET | Lind Global Fund III LPand 2 others | 13G/A | 1.40%51.9K shares | −6.47 ppfrom 7.87%Below 5% | Jun 30, 2026 | SEC |
| Aug 14, 202610:11 AM ET | Armistice Capital, LLCand 1 other | 13G | 9.99%405.1K shares | – | Jun 30, 2026 | SEC |
| Aug 13, 202612:40 PM ET | Ayrton Capital LLCand 2 others | 13G/A | 2.93%111.1K shares | −7.06 ppfrom 9.99%Below 5% | Jun 30, 2026 | SEC |
| May 15, 20264:15 PM ET | Lind Global Fund III LPand 2 others | 13G/A | 7.87%161.2K shares | −2.12 ppfrom 9.99% | Mar 31, 2026 | SEC |
| Feb 4, 20264:31 PM ET | Lind Global Fund III LPand 2 others | 13G | 9.99%141.3K shares | New | Jan 28, 2026 | SEC |
| Feb 2, 20268:29 PM ET | Intracoastal Capital, LLCand 2 others | 13G | 4.99%71.2K shares | 0.00 ppfrom 4.99%Below 5% | Jan 27, 2026 | SEC |
| Jan 5, 202612:39 PM ET | AdvisorShares Trust | 13G/A | 1.66%17.0K shares | −4.61 ppfrom 6.27%Below 5% | Dec 31, 2025 | SEC |
| Dec 17, 20258:20 PM ET | Intracoastal Capital, LLCand 2 others | 13G | 4.99%31.4K shares | NewBelow 5% | Dec 11, 2025 | SEC |
| Dec 10, 20253:47 PM ET | Braeden Lichtiand 1 other | 13G/A | 0.00%0 shares | −5.01 ppfrom 5.01%Below 5% | Dec 9, 2025 | SEC |
| Dec 10, 20253:47 PM ET | Northstrive Fund II LPand 1 other | 13G/A | 0.00%0 shares | −5.01 ppfrom 5.01%Below 5% | Dec 9, 2025 | SEC |
| Dec 5, 20257:06 PM ET | Braeden Lichtiand 1 other | 13G | 5.01%29.9K shares | New | Dec 3, 2025 | SEC |
| Dec 5, 20255:40 PM ET | Northstrive Fund II LPand 1 other | 13G | 5.01%29.9K shares | New | Dec 3, 2025 | SEC |
| Nov 13, 20253:42 PM ET | Ayrton Capital LLCand 2 others | 13G | 9.99%658.5K shares | New | Sep 30, 2025 | SEC |
| Oct 3, 20255:51 PM ET | AdvisorShares Trust | 13G | 6.27%203.7K shares | +2.62 ppfrom 3.65% | Sep 30, 2025 | SEC |
| Sep 24, 20255:17 PM ET | Intracoastal Capital, LLCand 2 others | 13G | 0.40%19.3K shares | −4.59 ppfrom 4.99%Below 5% | Sep 18, 2025 | SEC |
| Apr 2, 20254:12 PM ET | AdvisorShares Trust | 13G/A | 3.65%90.3K shares | −2.25 ppfrom 5.90%Below 5% | Mar 31, 2025 | SEC |
| Feb 5, 20255:15 PM ET | Intracoastal Capital, LLCand 2 others | 13G | 4.99%104.0K shares | –Below 5% | Jan 30, 2025 | SEC |
| Feb 4, 20257:51 PM ET | Orca Capital AG | 13G/A | 4.90%97.0K shares | −3.80 ppfrom 8.70%Below 5% | Jan 31, 2025 | SEC |
| Feb 4, 20257:47 PM ET | Orca Capital AG | 13G | 8.70%166.7K shares | New | Jan 30, 2025 | SEC |
| Jan 6, 20255:04 PM ET | AdvisorShares Trust | 13G | 5.90%599.9K shares | – | Dec 31, 2024 | SEC |
| Nov 14, 2024 | Armistice Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Nov 13, 2024 | Intracoastal Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Nov 12, 2024 | AdvisorShares Trust | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Armistice Capital, LLC | 13GOld format | – | New | – | SEC |
| Feb 6, 2024 | Intracoastal Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 5, 2024 | Hudson Bay Capital Management LP | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | AdvisorShares Trust | 13GOld format | – | New | – | SEC |
| Feb 8, 2023 | Intracoastal Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 7, 2023 | Hudson Bay Capital Management LP | 13GOld format | – | New | – | SEC |
| Feb 6, 2023 | Alpha Capital Anstalt | 13G/AOld format | – | – | – | SEC |
| Aug 1, 2022 | Intracoastal Capital, LLC | 13GOld format | – | New | – | SEC |
| Jan 18, 2022 | Alpha Capital Anstalt | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2021 | TOP Invest LLC | 13GOld format | – | New | – | SEC |
| Feb 10, 2021 | Stefansky David | 13G/AOld format | – | – | – | SEC |
| Jan 19, 2021 | Stefansky David | 13GOld format | – | New | – | SEC |
| Jan 12, 2021 | TAF Group LLC | 13GOld format | – | New | – | SEC |
| Jan 12, 2021 | Chex Associates LLC | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Enveric Biosciences, Inc. shares.
No Form 144 notices for Enveric Biosciences, Inc. are on file.